ILLUMINA, INC. (ILMN) — SEC Filings

Latest SEC filings for ILLUMINA, INC. (ILMN), explained in plain English.

Sentiment Overview: 47 neutral, 1 mixed

Recent Filings (48)

• Illumina, Inc. Files 8-K: Director Departure, New Officer — 8-K · 2026-04-02T09:09:56-04:00 [neutral] Risk: low
  On April 2, 2026, Illumina, Inc. filed an 8-K report detailing the departure of a director and the appointment of a new officer. The filing also includes a Regu
• 8-K Filing — 8-K · 2025-11-25T00:00:00.000Z [neutral]
• Illumina Files 8-K Report — 8-K · 2025-11-12T00:00:00.000Z [neutral] Risk: low
  On November 10, 2025, Illumina, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updat
• Illumina's Q3 Net Income Plunges Amid Debt Increase — 10-Q · 2025-10-31T00:00:00.000Z [mixed] Risk: medium
  Illumina, Inc. reported a net income of $150 million for the three months ended September 28, 2025, a significant decrease from $705 million in the same period
• Illumina, Inc. Files 8-K with Financial Updates — 8-K · 2025-10-30T00:00:00.000Z [neutral] Risk: low
  On October 30, 2025, Illumina, Inc. filed an 8-K report detailing its financial results and operations. The filing includes financial statements and exhibits, p
• Illumina Posts Modest Q2 Revenue Growth Amidst Stable Operations — 10-Q · 2025-08-01T00:00:00.000Z [neutral] Risk: medium
  ILLUMINA, INC. reported product revenue of $1.05 billion for the three months ended June 29, 2025, compared to $1.02 billion for the same period in 2024, repres
• Illumina Files 8-K on Operations and Financials — 8-K · 2025-07-31T00:00:00.000Z [neutral] Risk: low
  On July 31, 2025, Illumina, Inc. filed an 8-K report to disclose information regarding its results of operations and financial condition, as well as financial s
• Illumina, Inc. Files 8-K Report — 8-K · 2025-06-23T00:00:00.000Z [neutral] Risk: low
  On June 22, 2025, Illumina, Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes other events and financial statements a
• Illumina Reports Director Departure and Stockholder Meeting — 8-K · 2025-05-23T00:00:00.000Z [neutral] Risk: low
  On May 21, 2025, Illumina, Inc. filed an 8-K report detailing several key events. The company announced the departure of director Dr. Scott Kahn, effective May
• Illumina 10-Q: Q1 2025 Financials Filed — 10-Q · 2025-05-09T00:00:00.000Z [neutral] Risk: medium
  Illumina, Inc. filed its 10-Q for the period ending March 30, 2025, reporting on its financial performance. The filing details financial data for the first quar
• Illumina Files 8-K on Operations and Financials — 8-K · 2025-05-08T00:00:00.000Z [neutral] Risk: low
  On May 8, 2025, Illumina, Inc. filed an 8-K report to disclose information regarding its results of operations and financial condition, as well as financial sta
• Illumina Files 2025 DEF 14A: Executive Compensation & Governance — DEF 14A · 2025-04-09T00:00:00.000Z [neutral] Risk: low
  Illumina, Inc. filed its DEF 14A on April 9, 2025, for the fiscal year ending December 28, 2024. The filing details executive compensation, board of directors,
• Illumina CFO Departs; Interim Appointed, New Director Joins Board — 8-K · 2025-03-25T00:00:00.000Z [neutral] Risk: medium
  On March 24, 2025, Illumina, Inc. announced the departure of Chief Financial Officer, Joydeep Goswami, effective March 25, 2025. The company also announced the
• Illumina Appoints New Directors, Updates CFO Employment Agreement — 8-K · 2025-03-24T00:00:00.000Z [neutral] Risk: medium
  On March 18, 2025, Illumina, Inc. announced changes in its board of directors and executive compensation. The company elected two new directors, Dr. David L. R.
• Illumina, Inc. Files 8-K Report — 8-K · 2025-03-10T00:00:00.000Z [neutral] Risk: low
  On March 10, 2025, Illumina, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific
• Illumina, Inc. Files 2024 10-K — 10-K · 2025-02-12T00:00:00.000Z [neutral] Risk: medium
  Illumina, Inc. filed its 2024 10-K report on February 12, 2025, detailing its fiscal year ending December 29, 2024. The company, a leader in laboratory analytic
• Illumina Files 8-K on Operations and Financials — 8-K · 2025-02-06T00:00:00.000Z [neutral] Risk: low
  On February 6, 2025, Illumina, Inc. filed an 8-K report to disclose information regarding its results of operations and financial condition, as well as financia
• Illumina Files 8-K on Financials — 8-K · 2025-01-14T00:00:00.000Z [neutral] Risk: low
  On January 14, 2025, Illumina, Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes financial statements an
• SC 13G/A Filing — SC 13G/A · 2024-12-06T00:00:00.000Z [neutral]
• SC 13G Filing — SC 13G · 2024-12-05T00:00:00.000Z [neutral]
• SC 13G/A Filing — SC 13G/A · 2024-11-12T00:00:00.000Z [neutral]
• Illumina Files Q3 2024 10-Q — 10-Q · 2024-11-06T00:00:00.000Z [neutral] Risk: low
  Illumina, Inc. filed its 10-Q for the period ending September 29, 2024. The company reported financial results for the third quarter of 2024, detailing revenues
• Illumina Files 8-K on Financials — 8-K · 2024-11-04T00:00:00.000Z [neutral] Risk: low
  On November 4, 2024, Illumina, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as f
• SC 13G/A Filing — SC 13G/A · 2024-11-04T00:00:00.000Z [neutral]
• Illumina Files 8-K on Director Changes and Compensation — 8-K · 2024-10-03T00:00:00.000Z [neutral] Risk: medium
  On October 3, 2024, Illumina, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing includes the election
• Illumina Terminates Material Definitive Agreement — 8-K · 2024-09-09T00:00:00.000Z [neutral] Risk: medium
  Illumina, Inc. announced on September 4, 2024, the termination of a material definitive agreement. The company also reported other events and filed financial st
• Illumina Completes GRAIL Acquisition — 8-K · 2024-09-05T00:00:00.000Z [neutral] Risk: medium
  On September 4, 2024, Illumina, Inc. announced the completion of its acquisition of GRAIL, LLC. The company stated that it has received the necessary regulatory
• SC 13G Filing — SC 13G · 2024-08-14T00:00:00.000Z [neutral]
• Illumina Files 10-Q for Q2 2024 — 10-Q · 2024-08-07T00:00:00.000Z [neutral] Risk: medium
  Illumina, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter of 20
• Illumina Files 8-K on Operations and Financials — 8-K · 2024-08-06T00:00:00.000Z [neutral] Risk: low
  On August 6, 2024, Illumina, Inc. filed an 8-K report to disclose information regarding its results of operations and financial condition, as well as financial
• SC 13G/A Filing — SC 13G/A · 2024-07-08T00:00:00.000Z [neutral]
• Illumina Files 8-K/A Amendment for Asset Acquisition Financials — 8-K/A · 2024-06-27T00:00:00.000Z [neutral] Risk: low
  Illumina, Inc. filed an 8-K/A on June 27, 2024, to amend its previous filing regarding the completion of an acquisition or disposition of assets. The amendment
• Illumina, Inc. Reports Material Definitive Agreement — 8-K · 2024-06-24T00:00:00.000Z [neutral] Risk: medium
  On June 21, 2024, Illumina, Inc. entered into a material definitive agreement related to the completion of an acquisition or disposition of assets. The filing a
• Illumina, Inc. Files 8-K for Material Definitive Agreement — 8-K · 2024-06-17T00:00:00.000Z [neutral] Risk: medium
  On June 17, 2024, Illumina, Inc. entered into a material definitive agreement, likely related to a financial obligation. The company, headquartered in San Diego
• Illumina Files 8-K/A Amendment — 8-K/A · 2024-06-06T00:00:00.000Z [neutral] Risk: low
  Illumina, Inc. filed an 8-K/A on June 6, 2024, to amend a previous filing regarding an event that occurred on June 3, 2024. The amendment pertains to 'Other Eve
• Illumina 8-K: Exit/Disposal Costs & Other Events — 8-K · 2024-06-03T00:00:00.000Z [neutral] Risk: medium
  On June 3, 2024, Illumina, Inc. filed an 8-K to report on cost associated with exit or disposal activities and other events. The filing does not contain specifi
• Illumina Stockholders Approve All Proposals at Annual Meeting — 8-K · 2024-05-20T00:00:00.000Z [neutral] Risk: low
  On May 16, 2024, Illumina, Inc. filed an 8-K report to announce the results of its 2024 Annual Meeting of Stockholders. The company reported that all proposals
• Illumina Files Q1 2024 10-Q — 10-Q · 2024-05-03T00:00:00.000Z [neutral] Risk: medium
  Illumina, Inc. filed its 10-Q for the period ending March 31, 2024. The company reported financial results for the first quarter of 2024, detailing revenues fro
• Illumina Files 8-K on Financials — 8-K · 2024-05-02T00:00:00.000Z [neutral] Risk: medium
  On May 2, 2024, Illumina, Inc. filed an 8-K report. The filing primarily concerns the company's financial condition and results of operations, with specific det
• Illumina Files 8-K for Regulation FD Disclosure — 8-K · 2024-04-12T00:00:00.000Z [neutral] Risk: low
  On April 12, 2024, Illumina, Inc. filed an 8-K report. The filing primarily concerns a Regulation FD Disclosure, indicating that the company is providing materi
• Illumina Appoints New Directors to Board — 8-K · 2024-04-09T00:00:00.000Z [neutral] Risk: low
  On April 4, 2024, Illumina, Inc. announced changes to its Board of Directors. Dr. Jonathan T. Millham and Ms. Susan L. Roth were appointed as Class II directors
• Illumina DEF 14A: Executive Compensation & Board Details — DEF 14A · 2024-04-04T00:00:00.000Z [neutral] Risk: medium
  Illumina, Inc. filed its DEF 14A on April 4, 2024, detailing executive compensation and board member information for the fiscal year ending December 29, 2023. T
• Illumina Files 2023 10-K, Details Product & Service Revenues — 10-K · 2024-02-16T00:00:00.000Z [neutral] Risk: medium
  Illumina, Inc. filed its 10-K on February 16, 2024, for the fiscal year ended December 31, 2023. The filing indicates the company's primary business is in labor
• SC 13G/A Filing — SC 13G/A · 2024-02-13T00:00:00.000Z [neutral]
• Illumina Files 8-K on Operations & Financial Condition — 8-K · 2024-02-08T00:00:00.000Z [neutral] Risk: low
  Illumina, Inc. filed an 8-K on February 8, 2024, to report on its results of operations and financial condition, as well as to include financial statements and
• BlackRock Amends Illumina Stake, Signals Institutional Confidence — SC 13G/A · 2024-01-25T00:00:00.000Z [neutral]
  BlackRock Inc. filed an amended SC 13G/A on January 25, 2024, indicating its ownership of Illumina Inc. common stock as of December 31, 2023. This filing, Amend
• Illumina Files 8-K/A Amending Prior Exit/Disposal Cost Report — 8-K/A · 2024-01-09T00:00:00.000Z [neutral]
  Illumina, Inc. (ILMN) filed an 8-K/A on January 9, 2024, amending a previous report from June 21, 2023, regarding 'Cost Associated with Exit or Disposal Activit
• Illumina 8-K Signals Executive/Compensation Change on Jan 4, 2024 — 8-K · 2024-01-04T00:00:00.000Z [neutral]
  Illumina, Inc. filed an 8-K on January 4, 2024, to report an event that occurred on the same date. This filing indicates a change in leadership or executive com